pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
pharmadog news

Browse

1,655 stories matching this filter · ← front page

★ save view↓export CSV
rangeto
sort
recentoldestsourcealpha
source
STAT785Endpoints586BioPharma Dive224onclive165BioSpace60Fierce Biotech59raps24
therapy area
allOncology81Cardiology27Psychiatry & CNS21Vaccines17Immunology17Rare Disease12Hepatology
  • STAT+: DOJ’s swift win in OhioHealth case should have hospitals studying their contracts, experts say
    The speed of DOJ's proposed antitrust settlement with OhioHealth should put other hospitals on notice, experts say.
    STAT · 1mo ago↗ source
  • FDA gives rejected drugs another chance in post-Makary era
    Did you receive a complete response letter in the past year? Now may be the time for a resubmission. In the wake of FDA Commissioner Marty Makary's departure last month, the agency has already ag…
    Endpoints · 1mo ago↗ source
  • FTC, four state AGs sue transgender health group over care standards
    The FTC and four state attorneys general have sued the main professional organization for gender-affirming care clinicians.
    STAT · 1mo ago
← prev
page 26 of 67
next →
6
Hematology6
Pulmonology5
Infectious Disease4
Ophthalmology3
Dermatology2
↗ source
  • NIH diversity programs doubled undergraduates’ odds of getting a Ph.D., 20-year study finds
    A new study found that two diversity-oriented programs supported by the NIH doubled the odds that an undergraduate would earn a Ph.D.
    STAT · 1mo ago↗ source
  • FDA warns telehealth companies over compounded GLP-1s
    The FDA has issued a new batch of warning letters to 25 telehealth companies, accusing them of making false and misleading claims in their marketing of compounded GLP-1 weight loss drugs. The let…
    Endpoints · 1mo ago↗ source
  • Luigi Mangione will assert psychiatric defense in murder case in UnitedHealthcare CEO’s killing
    Luigi Mangione plans to assert a psychiatric defense at his state murder trial, claiming he was suffering from extreme emotional disturbance when he gunned down UnitedHealthcare CEO Brian Thompson.
    STAT · 1mo ago↗ source
  • STAT+: Advocacy groups petition FDA to withdraw approval of ‘unsafe’ use of antibiotics given to livestock
    More than 60 organizations are urging the FDA to withdraw approval for what they called the “unsafe” use of antibiotics for preventing disease in food-producing livestock.
    STAT · 1mo ago↗ source
  • UK waitlist for Novo's Wegovy pill triples in week after approval, major online pharmacy says
    The waiting list at a UK online pharmacy for Novo Nordisk’s Wegovy pill now stands at 30,000 people a week after approval, in a sign of dramatic demand for the weight loss drug among patients ...
    Endpoints · 1mo ago↗ source
  • Hackers claim they stole Novo Nordisk AI models, manufacturing recipes
    Novo Nordisk got robbed and is in the unenviable position of being extorted by the thieves. At stake, according to a group that has claimed responsibility for a cyberattack, are some of Novo's mo…
    Endpoints · 1mo ago↗ source
  • In second reversal, FDA gives uniQure a green light to seek accelerated approval
    Regulatory flexibility appears to be back on the FDA’s menu following the departures of Marty Makary and Vinay Prasad. At the center of the debate, once again, is the ...
    Endpoints · 1mo ago↗ source
  • STAT+: FDA appears open to Moderna’s flu vaccine ahead of adcomm
    UniQure will submit Huntington's therapy for approval, Eli Lilly buys 4E Therapeutics, and more biotech news
    STAT · 1mo ago↗ source
  • STAT+: Pharmalittle: We’re reading about hackers extorting Novo, an FDA about-face, and more
    A cyber extortion group claimed ​to have stolen more than a terabyte of data from Novo Nordisk and said it is ‌exploring selling some of the data
    STAT · 1mo ago↗ source
  • STAT+: Is Abridge’s ‘patient centered’ claim a bridge too far?
    In this edition of AI Prognosis, Brittany Trang takes a close look at ambient scribe developer Abridge's claim about being patient-centered.
    STAT · 1mo ago↗ source
  • Trump administration will bring special ed to HHS
    Infant mortality rate dips, OTC naloxone options rise, and other health news from Morning Rounds
    STAT · 1mo ago↗ source
  • STAT+: Following dispute with FDA, UniQure is cleared to submit Huntington’s treatment for approval
    The FDA has reversed its opposition to a closely watched experimental treatment for Huntington’s disease, clearing a path for its maker.
    STAT · 1mo ago↗ source
  • Jazz turns to AbCellera for T cell engagers in up to $4.1B partnership
    For much of its first decade, Canadian antibody developer AbCellera signed partnership after partnership, securing 40 biopharma alliances that led to more than a dozen clinical-stage drug candidate…
    Endpoints · 1mo ago↗ source
  • Update: Spot Bio launches with $40M to study non-viral gene therapy for muscular dystrophy
    A startup with operations in California and China has quietly begun tests of a genetic medicine that could restore dystrophin, the vital muscle protein that is broken or missing in people born with…
    Endpoints · 1mo ago↗ source
  • Triveni Bio raises $65M ahead of upcoming readouts on eczema drugs
    Triveni Bio announced a $65 million Series C after its second asset for eczema entered clinical studies last month. The Series C was co-led by Ascenta Capital and Janus Henderson Investors and in…
    Endpoints · 1mo ago↗ source
  • Migraine biotech Vedana Therapeutics makes its debut with $46M Series A
    Vedana Therapeutics has emerged from stealth with $46 million in Series A proceeds with the goal of developing treatments that could free patients from migraines entirely. Available treatments fo…
    Endpoints · 1mo ago↗ source
  • Opinion: As a physician, I have never been more concerned about rates of congenital syphilis
    “As a physician and former public health official, I have never been more concerned about those rates of congenital syphilis,” writes Jeffrey D. Klausner.
    STAT · 1mo ago↗ source
  • Opinion: The quiet joy of being an oncologist
    “The privilege of oncology is not only that you get to cure people,” writes oncologist Khushali Jhaveri. “It is also that you are invited into the most honest rooms in…
    STAT · 1mo ago↗ source
  • Opinion: How STAT decided to keep ‘health care’ as two words
    “‘Health care’ is such a big word for STAT. It’s a cornerstone of our coverage,” says STAT director of editorial operations Sarah Mupo.
    STAT · 1mo ago↗ source
  • STAT+: A prominent VC explains why she’s against U.S. restrictions on investment in China’s drug industry
    Should the federal government try to slow — or even block — U.S. biotech deals that could benefit China?
    STAT · 1mo ago↗ source
  • Health groups say HHS is trying to 'rush reinstatement' of ACIP
    A group of health organizations has accused HHS of trying to use a “self-created crisis” to “rush reinstatement” of the CDC’s frozen vaccine advisory panel. The committee and its recommendations…
    Endpoints · 1mo ago↗ source
  • B cell therapy maker Be Bio stops hemophilia trial
    Be Biopharma disclosed in a federal clinical trials listing that it has terminated its study of a hemophilia B therapy made by editing a patient’s own cells. It was one of ...
    Endpoints · 1mo ago↗ source